skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Download report extract

For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. The results of the catalysts highlighted in our Q4 2018 Outlook Report can be found on Page 4. At the end of this report, we have included a list of Large Impact catalysts through early 2019.
Early Outlook Report 2019

Read also

  • Biomedtracker: follow the drug development process , Datamon...

    2020 Early Outlook Webinar

    By Michael Haydock

    Anticipate the biggest, most impactful expected catalysts of early 2020 with the guidance and insights from Pharma Intelligence. Building off Biomedtracker’s Early 2020 Outlook report, our live webinar will include market context for these upcoming milestones and additional insights from Datamonitor Healthcare’s Therapeutic Area Directors.

    Topics FDA

  • Biomedtracker: follow the drug development process , Meddevi...

    38th Annual J.P. Morgan Healthcare Conference Review

    The 38th Annual J.P. Morgan Healthcare Conference has concluded, and Biomedtracker and Meddevicetracker were there to bring you the important outcomes from the largest and most informative annual healthcare investment symposium in the industry.

  • Biomedtracker: follow the drug development process , Datamon...

    2019 Post-ASH Conference Report Extract

    Access vital post-ASH meeting reporting from the expert analysts at Datamonitor Healthcare and Biomedtracker.

    Topics

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: